VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Competitors

GBX 13.24 +0.03 (+0.19%)

As of 11:19 AM Eastern

CYBG vs. CCFS, CIHL, IL0A, BGSC, and SLS

Should you be buying VanEck Bionic Engineering UCITS ETF A Acc stock or one of its competitors? The main competitors of VanEck Bionic Engineering UCITS ETF A Acc include Charter Court Financial Services Grp (CCFS), Caribbean Investment (CIHL), Permanent TSB Group (IL0A), BMO Global Smaller Companies (BGSC), and Standard Life UK Smaller Companies Trust (SLS).

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Charter Court Financial Services Grp?

Charter Court Financial Services Grp (LON:CCFS) and VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations.

: In the previous week, Charter Court Financial Services Grp's average media sentiment score of 0.00 equaled VanEck Bionic Engineering UCITS ETF A Acc'saverage media sentiment score.
Company Overall Sentiment
Charter Court Financial Services Grp Neutral
VanEck Bionic Engineering UCITS ETF A Acc Neutral
: Charter Court Financial Services Grp pays an annual dividend of GBX 0.09 per share. VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. Charter Court Financial Services Grp pays out 0.2% of its earnings in the form of a dividend. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio.
: VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Charter Court Financial Services Grp, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Charter Court Financial Services Grp £221.10M 0.00 N/A £46.30 N/A
VanEck Bionic Engineering UCITS ETF A Acc £1.24B 0.15 N/A -£7.10 N/A
: Company Net Margins Return on Equity Return on Assets
Charter Court Financial Services Grp N/A N/A N/A
VanEck Bionic Engineering UCITS ETF A Acc N/A N/A N/A

Company	Overall Sentiment
Charter Court Financial Services Grp	Neutral
VanEck Bionic Engineering UCITS ETF A Acc	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Charter Court Financial Services Grp	£221.10M	0.00	N/A	£46.30	N/A
VanEck Bionic Engineering UCITS ETF A Acc	£1.24B	0.15	N/A	-£7.10	N/A

Company	Net Margins	Return on Equity	Return on Assets
Charter Court Financial Services Grp	N/A	N/A	N/A
VanEck Bionic Engineering UCITS ETF A Acc	N/A	N/A	N/A

Summary

VanEck Bionic Engineering UCITS ETF A Acc beats Charter Court Financial Services Grp on 3 of the 5 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Caribbean Investment?

Caribbean Investment (LON:CIHL) and VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) are both small-cap banks - regional - europe industry companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations.

: VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Caribbean Investment, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Caribbean Investment £29.20M 0.00 N/A £8.60 N/A
VanEck Bionic Engineering UCITS ETF A Acc £1.24B 0.15 N/A -£7.10 N/A
: Company Net Margins Return on Equity Return on Assets
Caribbean Investment N/A N/A N/A
VanEck Bionic Engineering UCITS ETF A Acc N/A N/A N/A
: In the previous week, Caribbean Investment's average media sentiment score of 0.00 equaled VanEck Bionic Engineering UCITS ETF A Acc'saverage media sentiment score.
Company Overall Sentiment
Caribbean Investment Neutral
VanEck Bionic Engineering UCITS ETF A Acc Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caribbean Investment	£29.20M	0.00	N/A	£8.60	N/A
VanEck Bionic Engineering UCITS ETF A Acc	£1.24B	0.15	N/A	-£7.10	N/A

Company	Net Margins	Return on Equity	Return on Assets
Caribbean Investment	N/A	N/A	N/A
VanEck Bionic Engineering UCITS ETF A Acc	N/A	N/A	N/A

Company	Overall Sentiment
Caribbean Investment	Neutral
VanEck Bionic Engineering UCITS ETF A Acc	Neutral

Summary

Caribbean Investment beats VanEck Bionic Engineering UCITS ETF A Acc on 2 of the 3 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Permanent TSB Group?

VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and Permanent TSB Group (LON:IL0A) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, media sentiment, risk and dividends.

: In the previous week, Permanent TSB Group had 1 more articles in the media than VanEck Bionic Engineering UCITS ETF A Acc. MarketBeat recorded 1 mentions for Permanent TSB Group and 0 mentions for VanEck Bionic Engineering UCITS ETF A Acc. VanEck Bionic Engineering UCITS ETF A Acc's average media sentiment score of 0.00 equaled Permanent TSB Group'saverage media sentiment score.
Company Overall Sentiment
VanEck Bionic Engineering UCITS ETF A Acc Neutral
Permanent TSB Group Neutral
: 5.4% of Permanent TSB Group shares are owned by institutional investors. 79.1% of Permanent TSB Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
: Permanent TSB Group has lower revenue, but higher earnings than VanEck Bionic Engineering UCITS ETF A Acc. VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Permanent TSB Group, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc £1.24B 0.15 N/A -£7.10 N/A
Permanent TSB Group £406M 0.00 £213M £0.43 N/A
: Permanent TSB Group has a net margin of 54.93% compared to VanEck Bionic Engineering UCITS ETF A Acc's net margin of 0.00%. Permanent TSB Group's return on equity of 10.65% beat VanEck Bionic Engineering UCITS ETF A Acc's return on equity.
Company Net Margins Return on Equity Return on Assets
VanEck Bionic Engineering UCITS ETF A Acc N/A N/A N/A
Permanent TSB Group 54.93% 10.65% 0.93%

Company	Overall Sentiment
VanEck Bionic Engineering UCITS ETF A Acc	Neutral
Permanent TSB Group	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc	£1.24B	0.15	N/A	-£7.10	N/A
Permanent TSB Group	£406M	0.00	£213M	£0.43	N/A

Company	Net Margins	Return on Equity	Return on Assets
VanEck Bionic Engineering UCITS ETF A Acc	N/A	N/A	N/A
Permanent TSB Group	54.93%	10.65%	0.93%

Summary

Permanent TSB Group beats VanEck Bionic Engineering UCITS ETF A Acc on 8 of the 9 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to BMO Global Smaller Companies?

VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and BMO Global Smaller Companies (LON:BGSC) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings, valuation and media sentiment.

: VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. BMO Global Smaller Companies pays an annual dividend of GBX 0.02 per share. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. BMO Global Smaller Companies pays out 0.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio.
: In the previous week, VanEck Bionic Engineering UCITS ETF A Acc's average media sentiment score of 0.00 equaled BMO Global Smaller Companies'average media sentiment score.
Company Overall Sentiment
VanEck Bionic Engineering UCITS ETF A Acc Neutral
BMO Global Smaller Companies Neutral
: VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than BMO Global Smaller Companies, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc £1.24B 0.15 N/A -£7.10 N/A
BMO Global Smaller Companies £303.85M 0.00 N/A £50.70 N/A
: Company Net Margins Return on Equity Return on Assets
VanEck Bionic Engineering UCITS ETF A Acc N/A N/A N/A
BMO Global Smaller Companies N/A N/A N/A

Company	Overall Sentiment
VanEck Bionic Engineering UCITS ETF A Acc	Neutral
BMO Global Smaller Companies	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc	£1.24B	0.15	N/A	-£7.10	N/A
BMO Global Smaller Companies	£303.85M	0.00	N/A	£50.70	N/A

Company	Net Margins	Return on Equity	Return on Assets
VanEck Bionic Engineering UCITS ETF A Acc	N/A	N/A	N/A
BMO Global Smaller Companies	N/A	N/A	N/A

Summary

VanEck Bionic Engineering UCITS ETF A Acc beats BMO Global Smaller Companies on 3 of the 5 factors compared between the two stocks.

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Standard Life UK Smaller Companies Trust?

VanEck Bionic Engineering UCITS ETF A Acc (LON:CYBG) and Standard Life UK Smaller Companies Trust (LON:SLS) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings and media sentiment.

: In the previous week, VanEck Bionic Engineering UCITS ETF A Acc's average media sentiment score of 0.00 equaled Standard Life UK Smaller Companies Trust'saverage media sentiment score.
Company Overall Sentiment
VanEck Bionic Engineering UCITS ETF A Acc Neutral
Standard Life UK Smaller Companies Trust Neutral
: VanEck Bionic Engineering UCITS ETF A Acc is trading at a lower price-to-earnings ratio than Standard Life UK Smaller Companies Trust, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc £1.24B 0.15 N/A -£7.10 N/A
Standard Life UK Smaller Companies Trust £222.48M 0.00 N/A £217.40 N/A
: Company Net Margins Return on Equity Return on Assets
VanEck Bionic Engineering UCITS ETF A Acc N/A N/A N/A
Standard Life UK Smaller Companies Trust N/A N/A N/A
: VanEck Bionic Engineering UCITS ETF A Acc pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.2%. Standard Life UK Smaller Companies Trust pays an annual dividend of GBX 0.08 per share. VanEck Bionic Engineering UCITS ETF A Acc pays out -0.4% of its earnings in the form of a dividend. Standard Life UK Smaller Companies Trust pays out 0.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. VanEck Bionic Engineering UCITS ETF A Acc is clearly the better dividend stock, given its higher yield and lower payout ratio.

Company	Overall Sentiment
VanEck Bionic Engineering UCITS ETF A Acc	Neutral
Standard Life UK Smaller Companies Trust	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VanEck Bionic Engineering UCITS ETF A Acc	£1.24B	0.15	N/A	-£7.10	N/A
Standard Life UK Smaller Companies Trust	£222.48M	0.00	N/A	£217.40	N/A

Company	Net Margins	Return on Equity	Return on Assets
VanEck Bionic Engineering UCITS ETF A Acc	N/A	N/A	N/A
Standard Life UK Smaller Companies Trust	N/A	N/A	N/A

Summary

VanEck Bionic Engineering UCITS ETF A Acc beats Standard Life UK Smaller Companies Trust on 3 of the 5 factors compared between the two stocks.

Get VanEck Bionic Engineering UCITS ETF A Acc News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CYBG vs. The Competition

Export

Metric	VanEck Bionic Engineering UCITS ETF A Acc	Banks Industry	Finance Sector	LON Exchange
Market Cap	£189.87M	£189.87M	£13.34B	£2.73B
Dividend Yield	2.25%	2.25%	5.80%	6.11%
P/E Ratio	-1.86	N/A	23.27	365.28
Price / Sales	0.15	15.34	181.74	87,989.37
Price / Cash	0.13	0.13	20.24	27.89
Price / Book	0.04	0.04	3.43	7.39
Net Income	N/A	N/A	£1.11B	£5.89B
7 Day Performance	-3.58%	-0.72%	0.03%	0.88%
1 Month Performance	N/A	-1.13%	4.66%	5.27%
1 Year Performance	-11.19%	-2.24%	13.62%	80.43%

VanEck Bionic Engineering UCITS ETF A Acc Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CYBG VanEck Bionic Engineering UCITS ETF A Acc	N/A	GBX 13.24 +0.2%	N/A	N/A	£189.87M	£1.24B	N/A	5,762
CCFS Charter Court Financial Services Grp	N/A	N/A	N/A	N/A	£713.62M	£221.10M	6.37	676	Gap Up
CIHL Caribbean Investment	N/A	N/A	N/A	N/A	£35.27M	£29.20M	3.08	N/A	Gap Up High Trading Volume
IL0A Permanent TSB Group	N/A	N/A	N/A	N/A	£12.99M	£406M	5.53	2,236
BGSC BMO Global Smaller Companies	N/A	N/A	N/A	N/A	£769.56M	£303.85M	2.77	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:CYBG) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Competitors

CYBG vs. CCFS, CIHL, IL0A, BGSC, and SLS

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Charter Court Financial Services Grp?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Caribbean Investment?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Permanent TSB Group?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to BMO Global Smaller Companies?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Standard Life UK Smaller Companies Trust?

Summary

Media Sentiment Over Time

CYBG vs. The Competition

VanEck Bionic Engineering UCITS ETF A Acc Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Competitors

CYBG vs. CCFS, CIHL, IL0A, BGSC, and SLS

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Charter Court Financial Services Grp?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Caribbean Investment?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Permanent TSB Group?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to BMO Global Smaller Companies?

Summary

How does VanEck Bionic Engineering UCITS ETF A Acc compare to Standard Life UK Smaller Companies Trust?

Summary

Media Sentiment Over Time

CYBG vs. The Competition

VanEck Bionic Engineering UCITS ETF A Acc Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools